Providence Regional Cancer System-Lacey — Lacey, Washington

Providence Regional Cancer System-Lacey is a clinical research site located in Lacey, Washington, United States 98503.

Crixeo Clinical Trials Trust Score: 35/100 (FAILING). This profile has not yet been claimed by the site owner.

Providence Regional Cancer System-Lacey has participated in 213 clinical trials with 144 currently active.

Therapeutic areas: Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lacey

Browse all research sites in Washington · View every site in Lacey

Sponsor Feasibility Report

Trust Score: 35/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Providence Regional Cancer System-Lacey?

Providence Regional Cancer System-Lacey has a Crixeo Trust Score of 35/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Providence Regional Cancer System-Lacey conducted?

Providence Regional Cancer System-Lacey has 213 clinical trials on record, with 144 currently active. Their work covers Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Is Providence Regional Cancer System-Lacey accredited by Crixeo Clinical Trials?

Providence Regional Cancer System-Lacey has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Providence Regional Cancer System-Lacey?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.